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Abstract
Methanol toxicity can result in serious morbidity and
mortality without timely diagnosis and treatment. Many
cases of methanol poisoning outbreaks have been noted in
our population but no study has been performed to
estimate methanol exposure and its outcomes and
complications. A retrospective study was conducted to
review all the cases of methanol poisoning admitted from
January 1988 to December 2015 at the Aga Khan University
Hospital. A total of 35 methanol poisoning cases were
reported. All the patients were male, and the mean age was
36.2±8.6 years. The mean Glasgow Coma Scale score on
presentation in the emergency was 10.4 ± 4.4. Blurring of
vision was present in 17 (48%) patients while 10 (28%) had
complete blindness. Mean arterial pH was 6.8±0.5 on
arrival. Ethanol was given to 30(88%) patients and 12(32%)
patients received bicarbonate for immediate treatment. A
total of 15 (42.8%) patients underwent dialysis, out of
which only 5 (33.3%) patients survived. Overall, 19 (54.3%)
patients expired secondary to methanol ingestion.
Keywords: Methanol, Poisoning, Tertiary healthcare,
Morbidity, Mortality.
Introduction
Methanol is a clear, colourless, and volatile liquid, and is
used as an industrial solvent, and  in a variety of
commercial products including windshield washer fluids.1
As it is cheap and easy to obtain, it is used in production
of illegal alcoholic beverages in Turkey.2 Poisoning due to
methanol is relatively uncommon in forensic practice,1
however methanol-related deaths have been reported in
literature,3 and several epidemics have been seen.4 The
toxicity of methanol is due to its metabolites,
formaldehyde and formic acid. Formic acid induces
severe metabolic acidosis which can be fatal and is the
primary agent responsible for ocular toxicity.5,6
Signs and symptoms of acute methanol poisoning include
weakness, blurring of vision, nausea, vomiting, headache,
epigastric pain, dyspnoea and cyanosis. If an increased
amount of methanol has been ingested, the outcomes can
include stupor, coma, convulsions, hypothermia, and death.
Blindness may result if the person survives.7 Poisoning with
methanol may be due to accidental or intentional ingestion,
including suicidal intent, abuse or misuse.8,9
As these alcoholic drinks are inexpensive, they are easily
accessible for people with low incomes. The aim of this
study was to find out the incidence, clinical presentation
and outcome of methanol poisoning at a tertiary care
centre in Karachi, Pakistan.
Methods and Results
A retrospective study was conducted of all the patients
admitted to Aga Khan University Hospital with the
diagnosis of methanol poisoning during period of
January 1988 to December 2015. Patients with recent
history of ingesting toxic amounts of methanol and
having osmolal gap of more than 10 mOsm/kg H2O were
included. Other inclusion criteria comprised of history of
or strong clinical suspicion of methanol poisoning and at
least two of the following criteria: arterial pH< 7.3; serum
bicarbonate < 20 meq/L (mmol/L); or osmolal gap >10
mOsm/kg H2O. Patients who were transferred out or left
against medical advice were excluded from our study. 
The study was approved by institutional ethical review
committee. Medical records of all the admitted patients
with the final diagnosis of methanol poisoning or with
other forms of alcohols including methanol were reviewed
and data were recorded on pre-designed performa. The
form included the patient's age, gender, clinical
presentation, initial laboratory workup, management and
outcomes. SPSS (version 19.0) was used for data analysis.
A total of 35 patients presented to our institute with
methanol poisoning. All of the patients were male with
mean age of 35.5±8.6 years and belonged to low
socioeconomic class. The mean Glasgow Coma Scale
(GCS) score on presentation in the emergency was
10.4±4.4. Most of the patients were symptomatic with 19
(76%) patients reporting visual symptoms, making it the
single most common clinical feature. Out of these,
17(48%) patients presented with blurry vision, 10 (28%)
with complete blindness while 8 (24%) had no visual
symptoms. Most of the patients presented with severe
metabolic acidosis with mean pH of 6.86±0.5. 
Most of the patients received ethanol 30(88%) as an
Vol. 67, No. 11, November 2017
1751
SHORT REPORT
Methanol poisoning: 27 years’ experience at a tertiary care hospital
Fareed Ahmed, Nadeem Ullah Khan, Noman Ali, Asher Feroze
Aga Khan University Hospital, Karachi, Pakistan.
Correspondence: Fareed Ahmed. Email: fareed.ahmed@aku.edu
antidote, and 12(32%) patients received bicarbonate as
immediate treatment. A total of 15 (42.8%) patients received
dialysis out of which only 5 (33.3%) patients survived.
Overall, a total of 19 (54.2%) patients expired secondary to
methanol ingestion.
Discussion
Methanol, also known as wood alcohol, is a constituent of
many commercially available industrial solvents and
alcoholic beverages. It remains a common source of
alcohol ingestion and poisoning among members of low
socioeconomic class. Although it has a relatively low
toxicity, the adverse effects result from accumulation of
formic acid, a metabolite of methanol metabolism.
Our study evaluated 35 patients with methanol poisoning.
Methanol causes visual impairment ranging from blurry
vision, or defects in colour vision to complete blindness in
severe poisoning.11 In our study, 17(48%) of the patients
presented with blurry vision, 10(28%) with complete
blindness while 8(24%) had no visual symptoms.
Most of the patients in our setup received ethanol as an
antidote as fomepizole is not available. Fomepizole is the
first line antidote recommended for methanol
poisoning,12 although ethanol was traditionally
administered for this purpose. Fomepizole has 500-1,000
times higher affinity for alcohol dehydrogenase than
ethanol and has been shown to decrease and reverse
visual impairment despite its potential to inhibit retinol
dehydrogense, an alcohol dehydrogenase isoenzyme
that is essential to vision, after methanol poisoning.13,14
A total of 19 (54.2%) patients had expired. It is evident
from this study that methanol poisoning still has a high
mortality rate despite improved treatment. This is mainly
due to delayed hospitalisation and presentation, leading
to an increased accumulation of formic acid formed from
methanol metabolism.
Our data does not reflect the actual incidence of
methanol poisoning in our country as majority of the
patients refer to government hospitals and most of the
patients die before seeking any medical treatment.
Conclusion
Methanol poisoning has a high mortality and morbidity
rate in our setting despite advanced treatment options
likely due to late presentation and degree of metabolic
acidosis. The use of buffer, antidotes and haemodialysis is
efficient if initiated early. For this reason, public education
about the consequences of methanol consumption
should be highlighted and government should take
necessary steps to control illicit activities.
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